This article has expired, however you can still
download the PDF.
Preview:
MANHASSET, N.Y., July 8, 2012 /PRNewswire-USNewswire/ -- Researchers at The Feinstein Institute for Medical Research have discovered that inflammation could be treated by targeting a molecule called the double-stranded RNA dependent protein kinase (PKR). T...